与年龄相关性黄斑变性相关的组织因子。
Tissue factor with age-related macular degeneration.
作者信息
Wang Guan-Feng, Zou Xiu-Lan
机构信息
Department of Ophthalmology, Guangzhou General Hospital of Guangzhou Military Command, Guangzhou 510010, Guangdong Province, China ; Jinan University, Guangzhou 510630, Guangdong Province, China.
出版信息
Int J Ophthalmol. 2012;5(5):609-13. doi: 10.3980/j.issn.2222-3959.2012.05.13. Epub 2012 Oct 18.
Abstract
Wet age-related macular degeneration which incidence increases year by year is a blinding eye disease, but current clinical methods of treatment on this disease are limited and the outcome is not ideal. Recent studies have found abnormally high expression of tissue factors which are targets for the treatment of wet age-related macular degeneration to achieve a certain effect in the choroidal neovascularization. Related literatures are reviewed as following.
摘要
湿性年龄相关性黄斑变性是一种致盲性眼病，其发病率逐年上升，但目前针对该疾病的临床治疗方法有限，治疗效果并不理想。最近的研究发现，组织因子表达异常增高，而组织因子是治疗湿性年龄相关性黄斑变性的靶点，在脉络膜新生血管形成方面可取得一定疗效。现将相关文献综述如下。
相似文献
1
Tissue factor with age-related macular degeneration.
Int J Ophthalmol. 2012;5(5):609-13. doi: 10.3980/j.issn.2222-3959.2012.05.13. Epub 2012 Oct 18.
2
Foveal atrophy and macular hole formation following intravitreal ranibizumab with/without photodynamic therapy for choroidal neovascularization secondary to age-related macular degeneration.
Clin Ophthalmol. 2011;5:167-70. doi: 10.2147/OPTH.S16947. Epub 2011 Feb 11.
3
[Vitreomacular adhesion in HD-OCT images in the age-related macular degeneration].
Klin Oczna. 2013;115(1):25-8.
4
Ranibizumab and aflibercept for the treatment of wet age-related macular degeneration.
Expert Opin Biol Ther. 2015;15(9):1349-58. doi: 10.1517/14712598.2015.1057565. Epub 2015 Jun 16.
5
Progression of lesion size in untreated eyes with exudative age-related macular degeneration: a meta-analysis using Lineweaver-Burk plots.
JAMA Ophthalmol. 2013 Mar;131(3):335-40. doi: 10.1001/jamaophthalmol.2013.818.
6
An efficacy analysis of anti-vascular endothelial growth factor therapy for choroidal neovascularization secondary to multifocal choroiditis and comparison with wet age-related macular degeneration.
J Zhejiang Univ Sci B. 2018;19(4):327-332. doi: 10.1631/jzus.B1700535.
7
Presumed macular choroidal watershed vascular filling, choroidal neovascularization, and systemic vascular disease in patients with age-related macular degeneration.
Am J Ophthalmol. 1998 Jan;125(1):71-80. doi: 10.1016/s0002-9394(99)80237-2.
8
Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: meta-analysis of 2-year safety results in three randomized clinical trials: Treatment Of Age-Related Macular Degeneration With Photodynamic Therapy and Verteporfin In Photodynamic Therapy Study Report no. 4.
Retina. 2004 Feb;24(1):1-12. doi: 10.1097/00006982-200402000-00001.
9
[Subretinal hemorrhage after intravitreal injection of anti-VEGF for age-related macular degeneration: a retrospective study].
J Fr Ophtalmol. 2009 May;32(5):309-13. doi: 10.1016/j.jfo.2009.04.001. Epub 2009 May 17.
10
EFFECT OF SYSTEMIC BETA-BLOCKERS, ACE INHIBITORS, AND ANGIOTENSIN RECEPTOR BLOCKERS ON DEVELOPMENT OF CHOROIDAL NEOVASCULARIZATION IN PATIENTS WITH AGE-RELATED MACULAR DEGENERATION.
Retina. 2015 Oct;35(10):1964-8. doi: 10.1097/IAE.0000000000000603.
引用本文的文献
1
New Therapies of Neovascular AMD-Beyond Anti-VEGFs.
Vision (Basel). 2018 Jul 30;2(3):31. doi: 10.3390/vision2030031.
2
The Contribution of Fluoride to the Pathogenesis of Eye Diseases: Molecular Mechanisms and Implications for Public Health.
Int J Environ Res Public Health. 2019 Mar 8;16(5):856. doi: 10.3390/ijerph16050856.
3
Protection of tight junction between RPE cells with tissue factor targeting peptide.
Int J Ophthalmol. 2018 Oct 18;11(10):1594-1599. doi: 10.18240/ijo.2018.10.04. eCollection 2018.
4
RPE phagocytic function declines in age-related macular degeneration and is rescued by human umbilical tissue derived cells.
J Transl Med. 2018 Mar 13;16(1):63. doi: 10.1186/s12967-018-1434-6.
本文引用的文献
1
Antiangiogenic therapy for ischemic retinopathies.
Cold Spring Harb Perspect Med. 2012 Jun;2(6):a006411. doi: 10.1101/cshperspect.a006411.
2
IL-33 is induced by amyloid-β stimulation and regulates inflammatory cytokine production in retinal pigment epithelium cells.
Inflammation. 2012 Apr;35(2):776-84. doi: 10.1007/s10753-011-9379-4.
3
The role of Bcl-xL in mouse RPE cell survival.
Invest Ophthalmol Vis Sci. 2011 Aug 17;52(9):6545-51. doi: 10.1167/iovs.10-6772.
4
C-reactive protein and complement factor H in aged human eyes and eyes with age-related macular degeneration.
Br J Ophthalmol. 2011 Sep;95(9):1323-30. doi: 10.1136/bjo.2010.199216. Epub 2011 Jun 1.
5
Transcriptional factors associated with epithelial-mesenchymal transition in choroidal neovascularization.
Mol Vis. 2011;17:1222-30. Epub 2011 May 6.
6
Characterization of conditioned media collected from aged versus young human eye cups.
Invest Ophthalmol Vis Sci. 2011 Jul 29;52(8):5963-72. doi: 10.1167/iovs.10-6440.
7
Evidence for enhanced tissue factor expression in age-related macular degeneration.
Lab Invest. 2011 Apr;91(4):519-26. doi: 10.1038/labinvest.2010.184. Epub 2010 Nov 1.
8
Animal models of choroidal and retinal neovascularization.
Prog Retin Eye Res. 2010 Nov;29(6):500-19. doi: 10.1016/j.preteyeres.2010.05.003. Epub 2010 May 19.
9
Aging, age-related macular degeneration, and the response-to-retention of apolipoprotein B-containing lipoproteins.
Prog Retin Eye Res. 2009 Nov;28(6):393-422. doi: 10.1016/j.preteyeres.2009.08.001. Epub 2009 Aug 19.
10
Factor VII-verteporfin for targeted photodynamic therapy in a rat model of choroidal neovascularization.
Invest Ophthalmol Vis Sci. 2009 Aug;50(8):3890-6. doi: 10.1167/iovs.08-2833. Epub 2009 Apr 8.
Zotero 插件